Examinants from World Health Organization (WHO) conducted on-site inspection for PQ Certification of streptomycin sulfate for injection of the new preparation branch in new park of North China Pharmaceutical (6.75,0.06,0.90%) from October 20-24, 2014 and the on-site inspection on North China Pharmaceutical was satisfactorily completed after 5 days. “North China” brand streptomycin sulfate sterile powder injection will be included in the procurement circle of the organization to participate in international bidding upon completing the subsequent final review.
This will be another non-penicillin and non-cephalosporin preparation product production line passing PQ on-site inspection of WHO of North China Pharmaceutical after penicillin preparation product production has passed WHO certification since launching international high-end certification engine for preparations in 2010, marking a new breakthrough of high-end certification of preparation of North China Pharmaceutical.
The 21 API international high-end certificates possessed by North China Pharmaceutical symbolizes that its API international certification is in the forefront among the peers. North China Pharmaceutical has currently obtained 40 international registered certificates for preparation variety, including 2 whole product chain high-end certificates of preparations. It is now accelerating and increasing its pace toward international certification of preparation, to sprint the international high-end market from behind.
